Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Novozymes A/S (NVZMY) had Revenue of $4.15B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$4.15B
Net Income	$330.91M
Cost of Goods Sold	$2.19B
Gross Profit	$1.96B
Operating Expenses	$3.61B
Operating Income	$542.13M
Non-Operating Income/Expense	$-90.79M
Pre-Tax Income	$451.34M
Normalized Pre-Tax Income	$451.34M
Income after Taxes	$330.91M
Income from Continuous Operations	$330.91M
Consolidated Net Income/Loss	$330.91M
Normalized Income after Taxes	$330.91M
EBIT	$542.13M
EBITDA	$542.13M
Weighted-Average Shares Outstanding (Basic)	457.62M
Weighted-Average Shares Outstanding (Diluted)	459.61M
Earnings per Share (EPS) (Basic)	$0.72
Earnings per Share (EPS) (Diluted)	$0.72
Balance Sheet Financials
Current Assets	$2.03B
Property, Plant, and Equipment	$3.21B
Long-Term Assets	$14.41B
Total Assets	$16.44B
Current Liabilities	$1.18B
Long-Term Debt	$1.66B
Long-Term Liabilities	$3.17B
Total Liabilities	$4.35B
Common Equity	$12.09B
Tangible Shareholders Equity	$1.25B
Shareholders Equity	$12.09B
Common Shares Outstanding	466.14M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.10B
Cash Flow from Investing Activities	$-216.10M
Cash Flow from Financial Activities	$-760.93M
Beginning Cash	$161.99M
End Cash	$302.99M
Increase/Decrease in Cash	$141.00M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-270.31M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.73
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.12
Debt to Equity Ratio	0.16
Gross Margin	47.20%
Operating Margin	13.07%
EBIT Margin	13.07%
EBITDA Margin	13.07%
Pre-Tax Profit Margin	10.88%
Profit Margin	7.98%
Free Cash Flow	$738.42M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.25
Inventory Turnover	2.81
Receiveable Turnover	4.57
Days Sales in Receivables	79.94
Return on Equity	2.74%
Return on Tangible Equity	26.55%
Return on Assets	2.01%
Return on Investments	2.41%
Book Value Per Share	$25.94
Free Cash Flow per Share	$1.61
Operating Cash Flow per Share	$2.40

Data from Zacks Investment Research, Inc.